Manufacturing Facilities
Genentech’s $700M North Carolina Plant and Telix’s FDA CRL Update
Genentech; Roche; North Carolina; manufacturing facility; $700 million; Holly Springs; metabolic medicines; obesity treatments; biomanufacturing; Telix; FDA; Complete Response Letter (CRL); imaging agent
BioNTech Halts Cell Therapy Manufacturing at Maryland Site, Lays Off Dozens
BioNTech; cell therapy; Maryland; layoffs; CAR-T; BNT211; Gaithersburg; manufacturing facility; cancer therapy; clinical trial